Spinal Tech

The global spinal implants and surgical devices market is expected to reach $21 billion by 2025, expanding at a compound annual growth rate of 6.1 percent from 2017 to 2025, Credence Research reports. 

Here are 18 key notes on orthopedic and spine device companies from the past week.

The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System.

The FDA cleared 59 orthopedic devices in December 2017.

Johnson & Johnson CEO Alex Gorsky spoke with CNBC at the J.P. Morgan Health Care Conference discussing tax reforms and the outlook for mergers and acquisitions in the medtech space.

Pompano Beach, Fla.-based medical device manufacturer Stimwave agreed to over $50 million in financing from undisclosed investors for its consumer launch of an opioid-free pain management microchip stimulator.

4WEB Medical saw a 57 percent boost in year-over-year growth in 2017.

Medtronic presented a plan to restructure the company at the J.P. Morgan Healthcare Conference and reported some of the details in a Securities and Exchange Commission filing, according to the Minneapolis/St. Paul Business Journal.

Orthofix released its preliminary 2017 fourth quarter and fiscal year 2017 year-end net sales results.

On Jan. 10, Misonix's president and CEO rang the Nasdaq Stock Market Closing Bell.